Topiramate: Antipsychotic-induced weight gain

Hospital Pharmacy

Volumn 49, Issue 4, 2014, Pages 345-347

  Generali, Joyce ^a   Cada, Dennis ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b Founder and Contributing ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; TOPIRAMATE;

ARTICLE; BODY WEIGHT DISORDER; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG DOSE TITRATION; DRUG PACKAGING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HOSPITAL PHARMACY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; WEIGHT GAIN;

EID: 84898944416     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4904-345     Document Type: Article

References (11)

1. Das C, Mendez G, Jagasia S, Labbate LA. Second-generation antipsychotic use in schizophrenia and associated weight gain: A critical review and meta-Analysis of behavioral and pharmacologic treatments. Ann Clin Psychiatry. 2012;24(3):225-239.
2. Fiedorowicz JG, Miller DD, Bishop JR, Calarge CA, Ellingrod VL, Haynes WG. Systematic review and meta-Analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers. Curr Psychiatry Rev. 2012;1;8(1):25-36.
3. McElroy SL, Suppes T, Keck PE, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry. 2000;47:1025-1033.
4. Littrell KH, Petty RG, Hiligoss NM, Peabody CD, Johnson CG. Weight loss with topiramate. Ann Pharmacother. 2001;35:1141-1142.
5. Chengappa RKN, Levine J, Rathore D, Parepally H, Atzert R. Long-term effects of topiramate on bipolar instability, weight change and glycemic control: A case-series. Eur Psychiatry. 2001;16:186-190.
6. Mahmood S, Booker I, Huang J, Coleman CI. Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents. J Clin Psychopharmacol. 2013;33(1):90-94.
7. Narula PK, Rehan HS, Unni KE, Gupta N. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebocontrolled trial. Schizophr Res. 2010;118(1-3):218-223.
8. Afshar H, Roohafza H, Mousavi G, et al. Topiramate add-on treatment in schizophrenia: A randomised, doubleblind, placebo-controlled clinical trial. J Psychopharmacol. 2009;23(2):157-62.
9. Khazaal Y, Chatton A, Rusca M, Preisig M, Zullino D. Long-term topiramate treatment of psychotropic druginduced weight gain: A retrospective chart review. Gen Hosp Psychiatry. 2007;29(5):446-449.
10. Egger C, Muehlbacher M, Schatz M, Nickel M. Infl uence of topiramate on olanzapine-related weight gain in women: An 18-month follow-up observation. J Clin Psychopharmacol. 2007;27(5):475-478.
11. Vieta E, Sanchez-Moreno J, Goikolea JM, et al. Effects on weight gain and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder. J Clin Psychopharmacol. 2004;24:374-378.